Characteristic | All patients | Patients with a TB diagnosis | Patients without a TB diagnosis | P value |
---|---|---|---|---|
(n = 427) | (n = 139) | (n = 288) | ||
 Age (years), median (IQR) | 36.1 (28.9–42.4) | 33.8 (27.2–39.7) | 37.1 (30.0–44.0) | 0.008 |
 Female | 259 (60.7) | 90 (64.8) | 169 (58.7) | 0.229 |
 New HIV diagnosis on admission | 82 (19.2) | 34 (24.5) | 48 (16.7) | 0.055 |
 History of previous TBa | 196 (46.1) | 50 (36.2) | 146 (50.9) | 0.005 |
ART status | ||||
 ART-naive | 177 (41.5) | 71 (51.1) | 106 (36.8) | 0.019 |
 ART interrupted | 71 (16.6) | 19 (13.7) | 52 (18.1) |  |
 Current ART use | 179 (41.9) | 49 (35.3) | 130 (45.1) |  |
 If currently on ART, treatment duration (years), median (IQR) | 1.6 (0.6–3.6) | 1.3 (0.2–2.9) | 1.7 (0.6–3.7) | 0.157 |
CD4 cell count (cells/uL) (n = 424) | ||||
 Median (IQR) cells/μL | 149 (55–312) | 80 (33–182) | 191 (73–392) | <0.001 |
 <50 | 94 (22.2) | 53 (38.4) | 41 (14.3) |  |
 50–99 | 66 (15.6) | 21 (15.2) | 45 (15.7) |  |
 100–149 | 53 (12.5) | 19 (13.8) | 34 (11.9) |  |
 150–199 | 42 (9.9) | 16 (11.6) | 26 (9.1) |  |
 ≥200 | 169 (39.9) | 29 (21.0) | 140 (49.0) |  |
Haemoglobin levels (n = 421) | ||||
 Median (IQR) | 9.6 (7.7–11.6) | 8.4 (6.8–10.2) | 10.2 (8.2–12.2) | <0.001 |
 No/mild anaemia | 144 (34.2) | 28 (20.1) | 116 (41.1) |  |
 Moderate/severe anaemia | 277 (65.8) | 111 (79.9) | 166 (58.9) |  |
Symptoms | ||||
 Cough ≥2 weeksa | 34 (8.0) | 18 (13.0) | 16 (5.6) | 0.008 |
 Sputum productiona | 161 (38.3) | 51 (37.5) | 110 (38.7) | 0.808 |
 Current cougha | 201 (47.4) | 84 (60.9) | 117 (40.9) | <0.001 |
 Current fevera | 63 (14.9) | 24 (17.5) | 39 (13.6) | 0.294 |
 Current night sweatsa | 174 (41.0) | 73 (52.9) | 101 (35.3) | 0.001 |
 Current reported weight lossa | 189 (44.5) | 76 (55.1) | 113 (39.4) | 0.002 |
 Positive WHO symptom screena | 389 (91.5) | 134 (97.1) | 255 (88.9) | 0.005 |